Spinal Instrumented Fusion in Combination with Botulinum Toxin Treatment for Cervical Myelopathy in Patients with Athetoid Cerebral Palsy

Main Article Content

Takeo Furuya

Abstract

Objective. To report the surgical outcomes and the details of perioperative botulinum toxin treatment of patients with cervical myelopathy associated with athetoid cerebral palsy.

Summary of Background Data. Recently, injections of botulinum toxin have been widely used to decrease spasticity and involuntary movements associated with athetosis or dystonia. Studies focusing on the details of botulinum toxin treatment are rare.

Methods. For patients who underwent surgery with spinal instrumented fusion in combination with perioperative botulinum toxin treatment, surgical outcomes, the details of botulinum toxin treatment and perioperative complications were investigated retrospectively.

Results: Of 17 patients, 15 underwent surgery by posterior methods, and 2 underwent anterior and posterior combined procedures. The mean preoperative Japanese Orthopedic Association (JOA) score was 6.9±2.4. At the final follow-up visit, the mean JOA score was 9.2±3.3, and the mean recovery rate was 23%. Botulinum toxin treatment suppressed involuntary neck movements in all patients. Halo vest immobilization was adapted for six patients preoperatively and for four patients postoperatively. The major complication in relation to surgery was implant failure. One patient developed mild dysphasia after an injection of botulinum toxin, but it improved after conservative therapy.

Discussion & Conclusion: Botulinum toxin treatment was performed safely and was effective in the management of involuntary neck movements. With botulinum toxin treatment, we were able to obtain relatively good surgical outcomes even if we did not use halo vest immobilization in many cases. However, we still faced a high rate of implant failures in the postoperative period. Using relatively strong external fixation, such as halo vest immobilization, together with botulinum toxin treatment may be an option for cervical myelopathy in patients with severe involuntary neck movements.

Article Details

How to Cite
FURUYA, Takeo. Spinal Instrumented Fusion in Combination with Botulinum Toxin Treatment for Cervical Myelopathy in Patients with Athetoid Cerebral Palsy. Medical Research Archives, [S.l.], v. 4, n. 7, nov. 2016. ISSN 2375-1924. Available at: <http://journals.ke-i.org/index.php/mra/article/view/853>. Date accessed: 20 jan. 2018.
Keywords
Cervical myelopathy, Athetoid cerebral palsy, Involuntary movement, Botulinum toxin, Surgical outcome, Complication
Section
Research Articles

References

1. Adler CH, Zimmerman RS, Lyons MK, et al. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord 1996; 11: 79-81.
2. Anderson WW, Wise BL, Itabashi HH, et al. Cervical spondylosis in patients with athetosis. Neurology 1962; 12: 410-2.
3. Azuma S, Seichi A, Ohnishi I, et al: Long-term results of operative treatment for cervical spondylotic myelopathy in patients with athetoid cerebral palsy. Spine 2002; 27: 943-8.
4. Demura S, Murakami H, Kawahara N, et al. Laminoplasty and pedicle screw fixation for cervical myelopathy associated with athetoid cerebral palsy. Spine 2013; 20: 1764-9.
5. Duruflé A, Pétrilli S, Le Guiet JL, et al. Cervical spondylotic myelopathy in athetoid cerebral palsy patients: about five cases. Joint Bone Spine 2005; 72: 270-4.
6. Ebara S, Yamazaki Y, Harada T, et al. Motion analysis of the cervical spine in athetoid cerebral palsy. Extension-flexion motion. Spine 1990; 15: 1097-103.
7. Epstein NE. Circumferential cervical surgery for spondylostenosis with kyphosis in two patients with athetoid cerebral palsy. Surg Neurol 1999; 52: 339-44.
8. Furuya T, Yamazaki M, Okawa A, et al. Cervical myelopathy in patients with athetoid cerebral palsy. Spine (Phila Pa 1976). 2013; 38: E151-7.
9. Gasser T, Fritsch K, Arnold G, et al. Botulinum toxin A in orthopaedic surgery. Lancet 1991; 338: 761.
10. Harada T, Ebara S, Anwar MM, et al. The cervical spine in athetoid cerebral palsy: a radiological study of 180 patients. J Bone Joint Surg Br 1996; 78: 613-9.
11. Haro H, Komori H, Okawa A, et al. Surgical treatment of cervical spondylotic myelopathy associated with athetoid cerebral palsy. J Orthop Sci 2002; 7: 629-36.
12. Hirabayashi K, Miyakawa J, Satomi K, et al. Operative results and postoperative progression of ossification among patients with ossification of cervical posterior longitudinal ligament. Spine 1981; 6: 354-64.
13. Jameson R, Rech C, Garreau de Loubresse C. Cervical myelopathy in athetoid and dystonic cerebral palsy: retrospective study and literature review. Eur Spine J 2010; 19: 706-12.
14. Jankovic J, Schwartz PA. Botulinum toxin injections for cervical dystonia. Neurology 1990; 40: 277-80.
15. Kim KN, Ahn PG, Ryu MJ, et al. Long-term surgical outcomes of cervical myelopathy with athetoid cerebral palsy. Eur Spine J. 2014; 23:1464-71.
16. Lee CK, Ha Y, Cho SR, et al. Clinical outcomes of correcting cervical deformity in cerebral palsy patients. World Neurosurg. 2016 [Epub ahead of print].
17. Lee YJ, Chung DS, Kim JT, et al. Surgical treatments for cervical spondylotic myelopathy associated with athetoid cerebral palsy. J Korean Neurosurg Soc 2008; 43: 294-9.
18. Levine RA, Rosenbaum AE, Waltz JM, et al. Cervical spondylosis and dyskinesias. Neurology 1970; 20: 1194-9.
19. Masaki Y, Yamazaki M, Okawa A, et al. An analysis of factors causing poor surgical outcome in patients with cervical myelopathy due to ossification of the posterior longitudinal ligament: anterior decompression with spinal fusion versus laminoplasty. J Spinal Disord Tech 2007; 20: 7-13.
20. Mihara H, Kondo S, Kohno M, et al. Clinical analysis of reoperation following surgical treatments for cervical spondylotic myelopathy accompanied with athetoid cerebral palsy. Rynsho Seikeigeka 2008; 43: 465-72 (Japanese).
21. Miyamoto H, Uno K, Inui Y, et al. Indications and limitations of posterior reconstruction surgery for 100 cases of non-traumatic disorders in the middle and the lower cervical spine. J Japanese Society Spine Surg Relat Res 2009; 20: 755-60.
22. Priori A, Berardelli A, Mercuri B, et al. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 1995; 118: 801-7.
23. Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases. J Neurosurg 1998; 88: 328-30.
24. Traynelis VC, Ryken T, Rodnitzky RL, et al. Botulinum toxin enhancement of postoperative immobilization in patients with cervical dystonia. Technical note. Neurosurg 1992; 77: 808-9.
25. Ueda Y, Yoshikawa T, Koizumi M, et al. Cervical laminoplasty combined with muscle release in patients with athetoid cerebral palsy. Spine 2005; 30: 2420-3.
26. Wong AS, Massicotte EM, Fehlings MG. Surgical treatment of cervical myeloradiculopathy associated with movement disorders: indications, technique, and clinical outcome. J Spinal Disord Tech 2005; 18 Suppl: S107-14.
27. Zhou H, Liu ZJ, Wang SB, et al. Laminoplasty with lateral mass screw fixation for cervical spondylotic myelopathy in patients with athetoid cerebral palsy: A retrospective study. Medicine (Baltimore). 2016; 95: e5033.

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.